Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

neurodegenerative diseases/proline

Länken sparas på Urklipp
ArtiklarKliniska testerPatent
9 resultat

Proline or proline derivatives for the treatment of dementia

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The invention relates to pharmaceutical composition comprising proline derivatives, preferably Cis-4-hydroxy-I-proline (CHP) and trans-4-Hydroxy-L-proline (THP), or proline, or their salts, esters, isomers, racemates, enantiomers or pro-drugs thereof, and to the use of said compositions for the

Therapeutic proline derivatives

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION This invention relates to proline derivatives useful as pharmaceutical agents, to processes for their production, to pharmaceutical compositions containing them, and to their use for the treatment of the conditions set out below. BACKGROUND TO THE INVENTION Gabapentin

Co-crystal forms of a novobiocin analog and proline

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND Approximately 26 million Americans are afflicted with either Type 1 or Type 2 diabetes. Despite the use of insulin and oral anti-diabetic medications to help maintain euglycemia, about 60-70% of these individuals develop diabetic peripheral neuropathy (DPN). See Veves, A.; Backonja, M.;

Structural mimetics of proline-rich peptides and the pharmaceutical use thereof

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This is the U.S. national stage of International application PCT/DE2007/001768, filed Sep. 25, 2007 designating the United States and claiming priority to European Applications EP 0609078.2, filed Sep. 25, 2006; EP 06090179.0, filed Sep. 25, 2006; and EP 07090095.6, filed May 7, 2007 and German

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATIONS The present application is a 35 U.S.C. .sctn.371 National Stage patent application of International patent application PCT/AT2009/000071, filed on Feb. 23, 2009, which claims priority to Austria patent application A297/2008, filed on Feb. 22, 2008. The present

Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF INVENTION The present invention relates to substances and compositions for the prevention and treatment of diseases or pathological states related to the degradation of the extracellular matrix, such as including but not limited to degenerative diseases, particularly arteriosclerosis,

Analogs of glycyl-prolyl-glutamate

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The present invention relates to novel analogs of Glycyl-Prolyl-Glutamate (GPE) and methods of their use. Additionally, this invention relates to the use of these compounds and pharmaceutical compositions thereof in the treatment of diseases and conditions characterised by

Antibodies for the selective determination of procalcitonin 1-116

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS REFERENCE TO RELATED APPLICATIONS This application is a 371 filing of PCT International application no. PCT/EP2008/001373 filed Feb. 21, 2008 and published in English as WO 2008/104321 A1 on Sep. 4, 2008, which claims the priority of German application no. 102007009751.6 filed Feb. 28, 2007.
The invention relates to the area of medical diagnosis, in particular the determination of biomarkers in biological fluids by means of immunodiagnostic methods. More precisely, the invention relates to the determination of the peptide procalcitonin for diagnostic purposes, a selective measured value
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge